Germany, March 31 -- Germany based AbbVie Deutschland GmbH & Co. KG has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V for the fixed active ingredient combination Glecaprevir and Pibrentasvir. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....